Candida virulence and ethanol-derived acetaldehyde production in oral cancer and non-cancer subjects

Oral Diseases

Volumn 22, Issue 8, 2016, Pages 805-814

  Alnuaimi, A D ^a   Ramdzan, A N ^b   Wiesenfeld, D ^a,c   O'Brien Simpson, N M ^a   Kolev, S D ^b   Reynolds, E C ^a   McCullough, M J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

acetaldehyde; Candida albicans; carcinogens; microbial induced carcinogenesis; oral cancer

Indexed keywords

ACETALDEHYDE; AGAR; ALCOHOL; CRYSTAL VIOLET; ESTERASE; HYDROLASE; PHOSPHOLIPASE; PROTEINASE;

ALCOHOL METABOLISM; ARTICLE; BIOFILM; CANDIDA; CANDIDA ALBICANS; CONTROLLED STUDY; FEMALE; FUNGAL METABOLISM; FUNGAL VIRULENCE; FUNGUS ISOLATION; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS; MOUTH CANCER; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; XTT ASSAY;

EID: 84990833575     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12565     Document Type: Article

References (44)

1. Alnuaimi AD, O'Brien-Simpson NM, Reynolds EC, McCullough MJ (2013). Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms. FEMS Yeast Res 13: 689–699.
2. Alnuaimi AD, Wiesenfeld D, O'Brien-Simpson NM, Reynolds EC, Peng B, McCullough MJ (2014). The development and validation of a rapid genetic method for species identification and genotyping of medically important fungal pathogens using high resolution melting curve analysis. Mol Oral Microbiol 29: 117–130.
3. Alnuaimi AD, Wiesenfeld D, O'Brien-Simpson NM, Reynolds EC, McCullough MJ (2015). Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study. Oral Oncol 51: 139–145.
4. Beausejour A, Grenier D, Goulet JP, Deslauriers N (1998). Proteolytic activation of the interleukin-1beta precursor by Candida albicans. Infect Immun 66: 676–681.
5. Boffetta P, Hashibe M (2006). Alcohol and cancer. Lancet Oncol 7: 149–156.
6. Brooks PJ, Theruvathu JA (2005). DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 35: 187–193.
7. Calderone RA, Fonzi WA (2001). Virulence factors of Candida albicans. Trends Microbiol 9: 327–335.
8. Chakrabarti A, Nayak N, Talwar P (1991). In vitro proteinase production by Candida species. Mycopathologia 114: 163–168.
9. Field EA, Field JK, Martin MV (1989). Does Candida have a role in oral epithelial neoplasia? J Med Vet Mycol 27: 277–294.
10. Gainza-Cirauqui ML, Nieminen MT, Novak Frazer L, Aguirre-Urizar JM, Moragues MD, Rautemaa R (2013). Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders. J Oral Pathol Med 42: 243–249.
11. Ghannoum MA (2000). Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13: 122–143.
12. Homann N, Tillonen J, Meurman JH et al (2000a). Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis 21: 663–668.
13. Homann N, Tillonen J, Salaspuro M (2000b). Microbially produced acetaldehyde from ethanol may increase the risk of colon cancer via folate deficiency. Int J Cancer 86: 169–173.
14. Hooper SJ, Wilson MJ, Crean SJ (2009). Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck 31: 1228–1239.
15. Karin M, Greten FR (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749–759.
16. Kumar CP, Menon T, Sundararajan T et al (2006). Esterase activity of Candida species isolated from immunocompromised hosts. Rev Iberoam Micol 23: 101–103.
17. Kurago ZB, Lam-ubol A, Stetsenko A, De La Mater C, Chen Y, Dawson DV (2008). Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation. Head Neck Pathol 2: 1–12.
18. Kurkivuori J, Salaspuro V, Kaihovaara P et al (2007). Acetaldehyde production from ethanol from by oral streptococci. Oral Oncol 43: 181–186.
19. Lax AJ (2005). Opinion: bacterial toxins and cancer–a case to answer? Nat Rev Microbiol 3: 343–349.
20. Mane A, Gaikwad S, Bembalkar S, Risbud A (2012). Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals. J Med Microbiol 61: 285–290.
21. Manfredi M, McCullough MJ, Al-Karaawi ZM, Vescovi P, Porter SR (2006). In vitro evaluation of virulence attributes of Candida spp. isolated from patients affected by diabetes mellitus. Oral Microbiol Immunol 21: 183–189.
22. Marttila E, Uittamo J, Rusanen P, Lindqvist C, Salaspuro M, Rautemaa R (2013). Acetaldehyde production and microbial colonization in oral squamous cell carcinoma and oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol 116: 61–68.
23. McCullough MJ, Clemons KV, Stevens DA (1999). Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol 37: 417–421.
24. McCullough M, Jaber M, Barrett AW, Bain L, Speight PM, Porter SR (2002). Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol 38: 391–393.
25. Mohd Bakri M, Mohd Hussaini H, Rachel Holmes A, David Cannon R, Mary Rich A (2010). Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma. J Oral Microbiol 2: doi:10.3402/jom.v2i0.5780.
26. Muto M, Hitomi Y, Ohtsu A et al (2000). Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: implications for carcinogenesis in upper aerodigestive tract. Int J Cancer 88: 342–350.
27. Nieminen MT, Uittamo J, Salaspuro M, Rautemaa R (2009). Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol 45: e245–e248.
28. Parahitiyawa NB, Samaranayake YH, Samaranayake LP et al (2006). Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 114: 298–306.
29. Pelucchi C, Gallus S, Garavello W, Bosetti C, La VC (2008). Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 17: 340–344.
30. Price MF, Wilkinson ID, Gentry LO (1982). Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20: 7–14.
31. Qianming C, Xin Z, Li B, Min Z (2004). The genotypic profiles of Candida albicans isolates from patients with oral leukoplakia and oral squamous cell carcinoma and the correlation with their virulence attribute. Cancer Res 45: 109.
32. Ramage G, Rajendran R, Sherry L, Williams C (2012). Fungal biofilm resistance. Int. J Microbiol 2012: 528521.
33. Ramdzan AN, Mornane PJ, McCullough MJ, Mazurek W, Kolev SD (2013). Determination of acetaldehyde in saliva by gas-diffusion flow injection analysis. Anal Chim Acta 786: 70–77.
34. Salaspuro MP (2003). Acetaldehyde, microbes and cancer of the digestive tract. Crit Rev Clin Lab Sci 40: 183–208.
35. Sardi JC, Duque C, Höfling JF, Gonçalves RB (2012). Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. Med Mycol 50: 467–475.
36. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ (2013). Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62: 10–24.
37. Schaller M, Mailhammer R, Grassl G, Sander CA, Hube B, Korting HC (2002). Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 118: 652–657.
38. Schaller M, Korting HC, Borelli C, Hamm G, Hube B (2005). Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect Immun 73: 2758–2765.
39. Seitz HK, Stickel F (2007). Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7: 599–612.
40. Silva S, Henriques M, Oliveira R, Williams D, Azeredo J (2010). In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol 61: 534–540.
41. Slifkin M (2000). Tween 80 opacity test responses of various Candida species. J Clin Microbiol 38: 4626–4628.
42. Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M (1999). Role of yeasts in the salivary acetaldehyde production from ethanol among risk groups for ethanol-associated oral cavity cancer. Alcohol Clin Exp Res 23: 1409–1415.
43. Treviño-Rangel Rde J, González JG, González GM (2013). Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex. Med Mycol 51: 331–335.
44. Zeng X, Xiong C, Wang Z et al (2008). Genotypic profiles and virulence attributes of Candida albicans isolates from patients with oral lichen planus. APMIS 116: 284–291.